Articles From: America's Car-Mart, Inc. Schedules Release of Fourth Quarter and Full Year 2013 Results and Conference Call to Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management


2013/5/7
Bentonville, Arkansas, May 7, 2013 (GLOBE NEWSWIRE) -- America's Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2013 fourth quarter financial results on Thursday May 23, 2013 after the market closes.
Sign-up for America's Car-Mart, Inc. Schedules Release of Fourth Quarter and Full Year 2013 Results and Conference Call investment picks
2013/5/7
American Express Co.
Sign-up for American Express Chief Financial Officer to Step Down investment picks
2013/5/7
The following announcement was issued today in a letter from Kenneth I.
Sign-up for American Express Organizational Announcement – Daniel T. Henry, Chief Financial Officer investment picks
2013/5/7
CLEVELAND , May 7, 2013 /PRNewswire/ -- This weekend, as people everywhere reach out to important mothers in their lives, they will also be looking to the greeting card aisle to find just the right message to express love and appreciation.
Sign-up for American Greetings Celebrates Moms Everywhere This Mother's Day investment picks
2013/5/7
$0.48 Impact to EPS Related to Force Reduction and One-Time Charge Free Cash Flow of $27.5M in FY13 Performance from Service Contracts Remains Strong AS&E's Board of Directors Approves $35 Million Stock Repurchase Program BILLERICA, Mass., May 7, 2013 (GLOBE NEWSWIRE) -- American Science and Engineering, Inc. (Nasdaq:ASEI) ("AS&E"), a leading worldwide supplier of innovative X-ray inspection solutions, today reported its financial results for the fourth quarter and fiscal year ended March 31, 2013.
Sign-up for American Science and Engineering, Inc. Reports Results for Fourth Quarter and Fiscal Year 2013 and Declares a Quarterly Dividend investment picks
2013/5/7
American Software, Inc. (NASDAQ: AMSWA) today announced that Vincent Klinges, the Company’s chief financial officer, will present at the 14 th Annual B.
Sign-up for American Software to Present at the 14th Annual B. Riley & Co. Investor Conference investment picks
2013/5/7
American Water Works Company, Inc. (NYSE: AWK) , the largest publicly traded U.S. water and wastewater utility company, today reported increases in revenues, net income and earnings per share for the first quarter ended March 31, 2013, as compared to the first quarter of 2012.
Sign-up for American Water Reports Strong First Quarter 2013 Results investment picks
2013/5/7
DERIDDER, La., May 7, 2013 (GLOBE NEWSWIRE) -- AMERISAFE, Inc. (Nasdaq:AMSF) , a specialty provider of high hazard workers' compensation insurance, today announced that C.
Sign-up for AMERISAFE to Present at 12th Annual JMP Securities Research Conference investment picks
2013/5/7
Study Meets Primary Endpoint of Non-Inferiority in Monotherapy Setting THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer investment picks
2013/5/7
Amgen Inc. (AMGN) said a late-stage trial testing its colon cancer drug Vectibix showed it was competitive with a rival option from German pharmaceutical and chemical company Merck KGaA (MKGAY, MRK.XE). Amgen said the trial put the drug "head-to-head" with Merck KGaA's Erbitux, considered a standard colon cancer therapy along with Vectibix and Avastin, made by Roche Holding AG's (ROG.VX) Genentech unit.
Sign-up for Amgen Late-Stage Trial of Colon Cancer Drug Meets Goal investment picks
2013/5/7
Amgen Inc. (AMGN) said a late-stage trial testing its colon cancer drug Vectibix showed it was competitive with a rival option from German pharmaceutical and chemical company Merck KGaA (MKGAY, MRK.XE). Amgen said the trial put the drug "head-to-head" with Merck KGaA's Erbitux, considered a standard colon cancer therapy along with Vectibix and Avastin, made by Roche Holding AG's (ROG.VX) Genentech unit.
Sign-up for Amgen Trial of Colon Cancer Drug Meets Goal investment picks
2013/5/7
SAN DIEGO , May 7, 2013 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AHS) , healthcare's workforce innovator and largest provider of staffing services, is scheduled to present on Wednesday, June 5, 2013 at 11:00 a.m. Eastern Time at the Jefferies 2013 Healthcare Conference taking place at the Grand Hyatt Hotel in New York , New York.
Sign-up for AMN Healthcare to Present at the Jefferies 2013 Healthcare Conference investment picks
2013/5/7
AmREIT, Inc. (NYSE:AMRE) (“AmREIT” or the “Company”), today announced financial results for the first quarter ended March 31, 2013 and dividends for the second quarter ended June 30, 2013.
Sign-up for AmREIT Reports First Quarter Results and Second Quarter Dividend investment picks
2013/5/7
Total First Quarter Revenue up 11% at $59.4 Million and Adjusted EPS increased to $0.23 ALBANY, N.Y. , May 7, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2013 .
Sign-up for AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year investment picks
2013/5/7
Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the first quarter ended March 31, 2013, on Thursday, May 9, 2013 at approximately 4:00 p.m. ET / 1:00 p.m. PT.
Sign-up for Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast investment picks
2013/5/7
GLEN ALLEN, Va.
Sign-up for Anatabloc® Brand Ambassador Fred Couples Inducted Into World Golf Hall of Fame investment picks
2013/5/7
NANJING , China , May 7, 2013 /PRNewswire/ -- China Sunergy Co., Ltd.
Sign-up for Announcement Made Pursuant to NASDAQ Listing Rule 5810(b) investment picks
2013/5/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0871999001&sourceType=1 http://media3.marketwire.com/logos/20120124-McEWbig.jpg TORONTO, ONTARIO --
Sign-up for Announcement: McEwen Mining First Quarter 2013 Conference Call May 9, 11:30 AM EST investment picks
2013/5/7
Two oral presentations at EULAR will review the impact of blisibimod on renal biomarkers and improved outcomes in systemic lupus erythematosus (SLE) patients HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study investment picks
2013/5/7
HOUSTON , May 7, 2013 /PRNewswire/ -- Apache Corporation (NYSE, Nasdaq: APA) today announced drilling success with three new discovery wells in Egypt 's Western Desert.
Sign-up for Apache announces three new oil and gas discoveries in egypt's western desert, extends production base across vast concession areas investment picks
2013/5/7
Apache Corp.
Sign-up for Apache Unveils Three Discoveries in Egypt investment picks
2013/5/7
Apco Oil and Gas International Inc. (NASDAQ:APAGF) today announced that for the three-month period ended March 31, 2013, it generated unaudited net income attributable to Apco of $9.9 million, or $0.34 per share, compared with net income of $10.1 million, or $0.34 per share for the same period in 2012.
Sign-up for Apco Reports First-Quarter Results investment picks
2013/5/7
Apollo Global Management, LLC (NYSE: APO) (“Apollo”) announced today a public offering for resale of approximately 21.1 million Class A shares owned by its strategic investors and certain of its managing partners, contributing partners and certain employees (collectively, the “Selling Shareholders”). The Selling Shareholders will grant to the underwriters of the offering an option to purchase up to approximately 3.2 million additional Class A shares.
Sign-up for Apollo Global Management Announces Launch of Public Offering of Class A Shares investment picks
2013/5/7
SAN FRANCISCO (MarketWatch) — A $60 billion share buyback announced by Apple Inc. two weeks ago has helped drive strong gains and high trading volumes for the stock, this year.
Sign-up for Apple shares juiced with ‘massive’ buyback investment picks
2013/5/7
SAN DIEGO, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that it will hold a conference call to discuss its first quarter 2013 financial results and recent corporate highlights on Friday, May 10, 2013 at 9:00 a.m. ET.
Sign-up for Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call investment picks
2013/5/7
SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that John P.
Sign-up for Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 Inhibitors at American Urological Association Annual Meeting investment picks
2013/5/7
Revenue increases 5.1 percent to $111.8 million GAAP earnings per share (diluted) for the quarter is $0.60; Costs related to pending merger with Nielsen reduced first quarter EPS by $0.12 COLUMBIA, Md.
Sign-up for Arbitron Inc. Reports 2013 First Quarter Financial Results investment picks
2013/5/7
http://media.marketwire.com/attachments/201206/56130_ARCDocumentSolutionsPR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014658&ProfileId=051205&sourceType=1 WALNUT CREEK, CA --
Sign-up for ARC Document Solutions Reports Results for First Quarter 2013 investment picks
2013/5/7
Architecture for Humanity, an international non-profit organization specializing in rebuilding areas damaged by natural disasters, announced today that it has opened a business development center in Ishinomaki City, which was devastated by the East Japan Great Earthquake and Tsunami in March 2011.
Sign-up for Architecture for Humanity to open MakiBiz in Ishinomaki City investment picks
2013/5/7
-- Arena to Receive $65 Million in Milestone Payments from Eisai --
Sign-up for Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: America's Car-Mart, Inc. Schedules Release of Fourth Quarter and Full Year 2013 Results and Conference Call to Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity